Edition:
India

Mediclinic International PLC (MDCM.L)

MDCM.L on London Stock Exchange

313.10GBp
21 Mar 2019
Change (% chg)

-1.90 (-0.60%)
Prev Close
315.00
Open
315.10
Day's High
317.20
Day's Low
311.10
Volume
553,662
Avg. Vol
1,729,630
52-wk High
712.40
52-wk Low
293.10

Latest Key Developments (Source: Significant Developments)

S.Africa's Competition Tribunal Stops Mediclinic Southern Africa- Matlosana Deal
Wednesday, 30 Jan 2019 

Jan 30 (Reuters) - S.AFRICA'S COMPETITION TRIBUNAL::PROHIBITED MERGER BETWEEN MEDICLINIC SOUTHERN AFRICA & MATLOSANA MEDICAL HEALTH SERVICES IN NORTH WEST PROVINCE.  Full Article

Mpilo Investment Holdings 2 (Rf) (Pty) Ltd Dissolves Stake In Mediclinic International Plc - Filing
Tuesday, 29 Jan 2019 

Jan 29 (Reuters) - Mediclinic International PLC ::MPILO INVESTMENT HOLDINGS 2 (RF) (PTY) LTD DISSOLVES STAKE IN MEDICLINIC INTERNATIONAL PLC - FILING.  Full Article

Mediclinic Says Forecast For Middle East Division Unchanged
Wednesday, 12 Dec 2018 

Dec 12 (Reuters) - Mediclinic International PLC ::GUIDANCE FOR MEDICLINIC MIDDLE EAST REMAINS UNCHANGED.MEDICLINIC MIDDLE EAST EXPECTS TO DELIVER FY19 REVENUE GROWTH IN HIGH SINGLE-DIGIT PERCENTAGE RANGE.  Full Article

Mediclinic Experiences Customary Seasonality In Switzerland, Middle East In H1 Trading
Wednesday, 17 Oct 2018 

Oct 17 (Reuters) - Mediclinic International PLC ::MEDICLINIC INTERNATIONAL - IN MIDDLE EAST, 182-BED MEDICLINIC PARKVIEW HOSPITAL IN DUBAI OPENED IN SEPTEMBER ON TIME AND IN BUDGET.MEDICLINIC INTERNATIONAL PLC - RECENTLY COMPLETED BUILD OF OUR FOURTH DAY CLINIC AT MEDICLINIC NEWCASTLE WHICH IS EXPECTED TO OPEN SHORTLY.MEDICLINIC INTERNATIONAL PLC - CONTINUE TO PROGRESS WITH HIRSLANDEN 2020 STRATEGIC PROGRAMME.MEDICLINIC INTERNATIONAL PLC - TRADING IN FIRST HALF OF YEAR EXPERIENCED CUSTOMARY SEASONALITY IN SWITZERLAND AND MIDDLE EAST.MEDICLINIC INTERNATIONAL PLC - IN MIDDLE EAST, WE DELIVERED A GRADUAL IMPROVEMENT IN REVENUE AND MARGIN EXPANSION IN H1.MEDICLINIC INTERNATIONAL PLC - IN SWITZERLAND, BUSINESS CONTINUES TO ADAPT TO RECENT REGULATORY CHANGES IN OUTPATIENT ENVIRONMENT IN H1.MEDICLINIC INTERNATIONAL PLC - IN SOUTHERN AFRICA, H1 MARGINS WERE MAINTAINED ON LOWER VOLUMES DUE TO WEAKNESS IN Q2.MEDICLINIC INTERNATIONAL PLC - FOR FULL YEAR, PERFORMANCE IN SOUTHERN AFRICA REMAINS IN LINE WITH GUIDANCE.MEDICLINIC INTERNATIONAL PLC - IN MIDDLE EAST, FULL YEAR EBITDA DELIVERY REMAINS ON TRACK WITH REVENUE GROWTH LOWER THAN PREVIOUSLY EXPECTED.MEDICLINIC INTERNATIONAL PLC - IN SWITZERLAND, WE NOW EXPECT TO DELIVER MODEST REVENUE GROWTH IN FULL YEAR.MEDICLINIC INTERNATIONAL PLC - AT GROUP LEVEL, IN CONSTANT CURRENCY, 1H19 REVENUE WAS UP 2% AND ADJUSTED EBITDA WAS DOWN AROUND 4%.  Full Article

Mediclinic International Says Guidance Remains Unchanged With Trading In Line With Expectations
Thursday, 28 Jun 2018 

June 28 (Reuters) - Mediclinic International PLC ::GUIDANCE REMAINS UNCHANGED WITH TRADING IN LINE WITH EXPECTATIONS.  Full Article

Mediclinic International Says CEO To Continue As A Non-Executive Director
Thursday, 24 May 2018 

May 24 (Reuters) - Mediclinic International PLC ::CHIEF EXECUTIVE OFFICER TO CONTINUE AS A NON-EXECUTIVE DIRECTOR.CHIEF EXECUTIVE OFFICER TO CONTINUE AS A NON-EXECUTIVE DIRECTOR.RONNIE VAN DER MERWE WILL SUCCEED MEINTJES AS CHIEF EXECUTIVE DIRECTOR ON 1 JUNE 2018.  Full Article

Mediclinic International appoints Carel Aron Van Der Merwe as CEO designate​
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Mediclinic International Plc ::‍ANNOUNCES APPOINTMENT OF CAREL ARON VAN DER MERWE, CURRENTLY GROUP CHIEF CLINICAL OFFICER, AS CHIEF EXECUTIVE OFFICER DESIGNATE​.MERWE ‍TO SUCCEED DANIE MEINTJES AS CEO OF COMPANY ON A DATE TO BE MUTUALLY AGREED, BUT NOT LATER THAN 1 AUGUST 2018​.  Full Article

Mediclinic International says H1 2018 ‍underlying EPS down 12 pct to 11.3 pence​
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - MEDICLINIC INTERNATIONAL PLC ::H1 2018 ‍UNDERLYING EARNINGS PER SHARE DOWN 12% TO 11.3 PENCE​.‍H1 REVENUE UP 10% TO GBP1 405M; FLAT IN CONSTANT CURRENCY TERMS​.‍H1 UNDERLYING EBITDA UP 5% TO GBP232M; DECREASED BY 5% IN CONSTANT CURRENCY TERMS​.‍INTERIM DIVIDEND MAINTAINED AT 3.20 PENCE PER SHARE​.SEES MODEST REVENUE GROWTH IN ‍HIRSLANDEN FOR H2​.‍FOR SOUTHERN AFRICA GROUP EXPECTS REVENUE GROWTH TO BE AROUND 4%​ IN H2.‍SEES MARGINAL IMPROVEMENT IN MIDDLE EAST REVENUES FOR FULL YEAR, GRADUAL IMPROVEMENT IN UNDERLYING EBITDA MARGINS OVER TIME,​.‍HAD A GOOD START TO SECOND HALF OF FINANCIAL YEAR, WITH CURRENT TRADING ACROSS ALL OPERATING DIVISIONS IN LINE WITH EXPECTATIONS​.‍GUIDANCE FOR ALL OPERATING DIVISIONS REMAINS UNCHANGED WITH CURRENT 2H18 TRADING IN LINE WITH MANAGEMENT​.  Full Article

Mediclinic confirms approach to Spire; says considering position
Monday, 23 Oct 2017 

Oct 23 (Reuters) - Mediclinic International Plc ::MEDICLINIC INTNL PLC - STATEMENT RE POSSIBLE OFFER.MEDICLINIC INTERNATIONAL PLC - ‍ANNOUNCEMENT REGARDING SPIRE HEALTHCARE GROUP PLC​.‍MEDICLINIC NOTES ANNOUNCEMENT MADE BY SPIRE HEALTHCARE GROUP PLC ("SPIRE") EARLIER TODAY​.MEDICLINIC - ‍CONFIRMS THAT IT MADE AN APPROACH TO SPIRE REGARDING A POSSIBLE OFFER FOR ENTIRE ISSUED AND TO BE ISSUED SHARE CAPITAL OF SPIRE​.‍PROPOSAL WAS REJECTED BY INDEPENDENT DIRECTORS OF SPIRE. AS A CONSEQUENCE, MEDICLINIC IS CONSIDERING ITS POSITION​.  Full Article

UK's Spire says rejects bid from Mediclinic Intl
Monday, 23 Oct 2017 

Oct 23 (Reuters) - Spire Healthcare Group Plc ::SPIRE HEALTHCARE GRP - RESPONSE TO PRESS SPECULATION.SPIRE HEALTHCARE - ‍RECEIVED PRELIMINARY AND CONDITIONAL PROPOSAL FROM MEDICLINIC INTERNATIONAL PLC.SPIRE HEALTHCARE - ‍RECEIVED PROPOSAL TO ACQUIRE ALL OF ISSUED AND TO BE ISSUED SHARES OF SPIRE WHICH MEDICLINIC DOES NOT ALREADY OWN​.‍PROPOSAL COMPRISED 150 PENCE IN CASH AND 0.232 NEW MEDICLINIC SHARES PER SPIRE SHARE​.‍PROPOSAL VALUED EACH SPIRE SHARE AT 298.6 PENCE PER SHARE​.BOARD ‍UNANIMOUSLY REJECTED OFFER ON BASIS THAT IT SIGNIFICANTLY UNDERVALUES SPIRE AND ITS PROSPECTS​.‍SHAREHOLDERS ARE STRONGLY ADVISED TO TAKE NO ACTION IN RELATION TO PROPOSAL​.‍THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE OR AS TO TERMS ON WHICH ANY OFFER MIGHT BE MADE​.  Full Article

Mediclinic H1 core profit down 8 percent on weak Swiss performance

JOHANNESBURG, Nov 15 Mediclinic International Plc reported a 8 percent decline in half-year core profit on Thursday reflecting a smaller contribution from Hirslanden, its Swiss operation.